Abstract
Non-Hodgkin lymphomas constitute 50% of all orbital malignancies. Mucosa-associatedlymphoid tissue (MALT)-type lymphoma is the most common histology category in thisanatomic region. Ocular adnexal lymphoma of MALT-type is an indolent and rarely lethalmalignancy that can often be managed with observation alone. Occasionally, lymphomatouslesions determine the symptoms that condition a patient’s quality of life, andso require an immediate antineoplastic treatment. Several strategies are available, butreliable indications supported by prospective trials do not exist. Some therapeuticstrategies are associated with substantial side effects and require a well-balancedtherapeutic decision, which should take into account several variables related to thepatient, the lymphoma, and the treatment itself. In this review, the authors analyzerelated literature and propose therapeutic guidelines for the management of ocular adnexallymphoma of MALT-type.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.